Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) EPS (Basic) (2016 - 2025)

Biomerica's EPS (Basic) history spans 15 years, with the latest figure at -$0.48 for Q4 2025.

  • For Q4 2025, EPS (Basic) fell 700.0% year-over-year to -$0.48; the TTM value through Nov 2025 reached -$2.51, up 25.52%, while the annual FY2025 figure was -$2.16, 23.94% up from the prior year.
  • EPS (Basic) for Q4 2025 was -$0.48 at Biomerica, down from $0.0 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.0 in Q3 2025 and bottomed at -$2.57 in Q2 2024.
  • The 5-year median for EPS (Basic) is -$0.12 (2021), against an average of -$0.37.
  • The largest annual shift saw EPS (Basic) crashed 2470.0% in 2024 before it soared 100.12% in 2025.
  • A 5-year view of EPS (Basic) shows it stood at -$0.09 in 2021, then tumbled by 33.33% to -$0.12 in 2022, then increased by 25.0% to -$0.09 in 2023, then soared by 33.33% to -$0.06 in 2024, then plummeted by 700.0% to -$0.48 in 2025.
  • Per Business Quant, the three most recent readings for BMRA's EPS (Basic) are -$0.48 (Q4 2025), $0.0 (Q3 2025), and -$1.98 (Q2 2025).